Details, Fiction and PXS-5153A
Here we clearly show that DNL343 lowers ISR activation and neurodegeneration introduced on acutely by an optic nerve crush (ONC) harm or chronically by a germline eIF2B LOF mutation in mice. We also present that DNL343 treatment, initiated in a late stage of disorder which much more precisely replicates a scientific dosing paradigm, reversed these